Home Medix HM-CV-20 vs ResMed AirSense 11 AutoSet

2 min read By HHZ Editorial Next review

The Home Medix HM-CV-20 is the value winner at roughly ₹28,000 and covers uncomplicated CPAP/APAP therapy with humidification and Windows/macOS Claro reporting. The ResMed AirSense 11 is the premium winner at roughly ₹63,390 for buyers who need AutoSet, touchscreen setup, myAir/AirView connectivity, heated-tube climate control, and a wider clinical ecosystem.

These machines sit two price tiers apart. Both provide CPAP/APAP across 4–20 cmH₂O with humidification, pressure relief, ramp, and therapy data. The difference is not basic pressure delivery; it is how much the buyer values ResMed’s connected comfort ecosystem.

FactorHM-CV-20AirSense 11 AutoSet
Indicative priceAbout ₹28,000About ₹63,390
Published sound<30 dB27 dB
Published weight1.45 kg1.1 kg
DataCard + Claro for Windows/macOSmyAir/AirView, Bluetooth/cellular by SKU, SD card
HumidificationIntegrated, manual levelsHumidAir, ClimateLineAir and climate-control ecosystem
InterfaceConventional controlsTouchscreen
Best fitValue-focused uncomplicated OSAConnected premium APAP

Where HM-CV-20 wins

Price-to-therapy value: the approximate ₹35,000 saving is meaningful. HM-CV-20 retains the standard APAP pressure range, integrated humidifier, expiratory relief, ramp, leak compensation, and event visibility.

Detailed offline reports: Home Medix Claro converts the memory card into therapy summaries, trends, aligned waveform panels, and event-level views on Windows or macOS. It is suitable for periodic clinical review when automatic cloud uploads are not mandatory.

India-side value proposition: a three-year/10,000-hour warranty and domestic service positioning can reduce dependence on premium imported-stock pricing—provided the local dealer is responsive.

Where AirSense 11 wins

Connected care: AirView and myAir can remove the manual memory-card handoff. This matters when a clinic actively monitors adherence or adjusts settings remotely.

Comfort stack: ClimateLineAir-compatible heated tubing and climate control can manage dryness and rainout better than a basic heated humidifier. Users in cold rooms or high AC settings may feel this difference every night.

Platform refinement: ResMed AutoSet, the touchscreen workflow, lower published weight, international travel recognition, and extensive clinician familiarity make AirSense 11 the stronger premium system.

The connectivity package can vary by region and seller. Confirm that the exact Indian SKU includes the modem or features you intend to use.

Which should you buy?

Choose HM-CV-20 when:

  • The diagnosis is uncomplicated obstructive sleep apnoea.
  • The budget is near ₹30,000.
  • Periodic card-based clinical review is acceptable.
  • Home Medix service is available in your city.

Choose AirSense 11 when:

  • The clinic uses AirView or expects automatic remote data.
  • Heated tubing and automatic climate control are adherence-critical.
  • International travel, premium accessories, and ecosystem depth matter.
  • The buyer accepts the higher total replacement cost.

If you want ResMed’s algorithm without AirSense 11 pricing, the AirSense 10 AutoSet is the logical middle option. See our wider AirSense 11 alternatives guide.

Verdict

HM-CV-20 is the commercial-value winner; AirSense 11 is the feature and ecosystem winner. For a straightforward APAP prescription, the Home Medix machine can deliver the core therapy at well under half the indicative price. Pay for AirSense 11 when its cloud workflow, climate comfort, and ResMed platform will actually be used.

Frequently asked questions

Is AirSense 11 worth twice the price of HM-CV-20?
It can be when automatic remote monitoring, ResMed AutoSet, heated-tube climate control, and premium ecosystem support are used. If those features are not required, HM-CV-20 offers stronger value.
Does HM-CV-20 have cloud reporting?
No. Claro reads the device memory card on Windows or macOS. It provides detailed reports but does not automatically upload each night.
Do both machines treat central sleep apnoea?
No. They may detect or flag central events, but standard CPAP/APAP is not ASV therapy and should not be selected to treat central sleep apnoea.